Evidence map›Paper›PMID 34315899›Full record

ArticleNature communications2021

Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy.

Mattia Manica, Giorgio Guzzetta, Flavia Riccardo, Antonio Valenti, Piero Poletti, Valentina Marziano, Filippo Trentini, Xanthi Andrianou, Alberto Mateo-Urdiales, Martina Del Manso and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Mattia ManicaCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.ORCID 0000-0003-3709-1199
Giorgio GuzzettaCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.
Flavia RiccardoIstituto Superiore di Sanità, Rome, Italy.ORCID 0000-0002-1582-6329
Antonio ValentiDepartment of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers' Compensation Authority (INAIL), Rome, Italy.
Piero PolettiCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.ORCID 0000-0001-5453-5199
Valentina MarzianoCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.ORCID 0000-0003-2842-7906
Filippo TrentiniCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.ORCID 0000-0001-6915-7282
Xanthi AndrianouIstituto Superiore di Sanità, Rome, Italy.
Alberto Mateo-UrdialesIstituto Superiore di Sanità, Rome, Italy.ORCID 0000-0002-0480-8723
Martina Del MansoIstituto Superiore di Sanità, Rome, Italy.
Massimo FabianiIstituto Superiore di Sanità, Rome, Italy.
Maria Fenicia VescioIstituto Superiore di Sanità, Rome, Italy.ORCID 0000-0002-3285-919X
Matteo SpuriIstituto Superiore di Sanità, Rome, Italy.
Daniele PetroneIstituto Superiore di Sanità, Rome, Italy.
Antonino BellaIstituto Superiore di Sanità, Rome, Italy.
Sergio IavicoliDepartment of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers' Compensation Authority (INAIL), Rome, Italy.
Marco AjelliDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.ORCID 0000-0003-1753-4749
Silvio BrusaferroIstituto Superiore di Sanità, Rome, Italy.
Patrizio PezzottiIstituto Superiore di Sanità, Rome, Italy.ORCID 0000-0002-0805-2927
Stefano MerlerCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy. merler@fbk.eu.ORCID 0000-0002-5117-0611
Istituto Superiore di Sanità · ITFondazione Bruno Kessler · ITIstituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro · ITCyprus University of Technology · CYNortheastern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To counter the second COVID-19 wave in autumn 2020, the Italian government introduced a system of physical distancing measures organized in progressively restrictive tiers (coded as yellow, orange, and red) imposed on a regional basis according to real-time epidemiological risk assessments. We leverage the data from the Italian COVID-19 integrated surveillance system and publicly available mobility data to evaluate the impact of the three-tiered regional restriction system on human activities, SARS-CoV-2 transmissibility and hospitalization burden in Italy. The individuals' attendance to locations outside the residential settings was progressively reduced with tiers, but less than during the national lockdown against the first COVID-19 wave in the spring. The reproduction number R(t) decreased below the epidemic threshold in 85 out of 107 provinces after the introduction of the tier system, reaching average values of about 0.95-1.02 in the yellow tier, 0.80-0.93 in the orange tier and 0.74-0.83 in the red tier. We estimate that the reduced transmissibility resulted in averting about 36% of the hospitalizations between November 6 and November 25, 2020. These results are instrumental to inform public health efforts aimed at preventing future resurgence of cases.

Indexed as

Communicable Disease ControlCOVID-19HumansItalySARS-CoV-2

Identifiers

PMID34315899
PMCPMC8316570
OpenAlexW3184091515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.